Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

NCRI 2018 | Head and neck cancer challenges & cetuximab trial updates

Name: Head and neck cancer challenges & cetuximab trial updates
Duration: 3 min 28 s

Quynh-Thu Le • 8 Nov 2018

NCRI 2018

Head and Neck Cancer Antibodies Cetuximab Cisplatin

De-ESCALaTE

The treatment of head and neck cancer comes with many challenges, as discussed here by Quynh-Thu Le, MD, from Stanford University, Stanford, CA, at the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK. Prof. Le highlights the key obstacles in this field, and discusses two current trials investigating cetuximab. This video was recorded at the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK.